Lupin and Avas Launch NaMuscla® in Italy Enables expanded access to the only EU-approved treatment for the myotonia symptoms in adults with non-dystrophic myotonic disorders Mumbai, Zug, January ...

Global pharma major Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas) today announced the launch of Lupin's orphan ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

We praise Rana S Hinman and colleagues 1 for their comprehensive investigation into the efficacy of telerehabilitation consultations versus in-person consultations for chronic knee pain management.

That’s where free trials come in. Not every streaming service offers free trials, but those that do, allow new users to test out the service for a set period of time, typically 7-30 days before ...

DRDO conducted a successful field evaluation trial of the Nag Mark 2 anti-tank guided missile in the Pokharan firing ranges, in Jaisalmer on Monday.(ANI ) Nag Mark-2 is the third-generation Anti ...

But he has refused to step down. Instead, he vowed to “fight to the end” to regain power through a trial at the Constitutional Court, and has resisted demands he submit to questioning by ...

Yoon's lawyers have indicated that he will show up for a hearing at an "appropriate time", but they have challenged the court's "unilateral decision" on trial dates. The court on Tuesday rejected ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...

Patient enrollment has been completed ahead of schedule in a Phase 2 clinical trial evaluating Contineum Therapeutics‘ PIPE-307, an oral therapy aiming to restore myelin — a process known as ...

While UHN reassures the public that the trials will be properly safeguarded, some concerns remain. The device — known as the N1 implant — is roughly the size of a coin, but it remains foreign material ...

The high-stakes trial of Terraform Labs co-founder Do Kwon is scheduled for January 26, 2026, in the U.S. District Court for the Southern District of New York. He'll spend the next year in federal ...